A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag
Clinical trial NCT07759804 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07759804
- Sponsor
- Liquidia Technologies, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.